Stockscreener 앱 받기
312.17
0.34%
1.07
시간 외 거래:
311.55
-0.62
-0.20%
Alnylam Pharmaceuticals Inc 주식(ALNY)의 최신 뉴스
Alnylam Pharmaceuticals (ALNY) reports $3B 2025 revenue driven by 151% TTR franchise surge - MSN
Alnylam Pharmaceuticals (NASDAQ:ALNY) Downgraded by Wall Street Zen to "Hold" - MarketBeat
Polar Asset Management Partners Inc. Reduces Holdings in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Alnylam and Tekmira Restructure Relationship and Settle All Litigation - Yahoo
Alnylam’s Cardiovascular RNAi Collaboration With Tenaya Might Change The Case For Investing In ALNY - Sahm
Can Alnylam's Pipeline Medications Drive Sustainable Growth in the Future? - Bitget
Can Alnylam's Pipeline Drugs Sustain Long-Term Growth Ahead? - Yahoo! Finance Canada
Novartis acquisition spin-off pioneers RNA therapeutics for the heart - Pharma Voice
Groupama Asset Managment Purchases 2,483,697 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
CIBC Private Wealth Group LLC Reduces Position in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Canaccord Genuity maintains buy rating on Alnylam Pharmaceuticals, Inc. (ALNY) stock - MSN
Alnylam’s research pact worth up to $1.1B sends Tenaya higher - MSN
Alnylam Pharmaceuticals Q2 2025 Earnings Preview - MSN
Here's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 20 Years - Benzinga
The $3B Biotech With Two Shots On Goal - Benzinga
Linden Advisors LP Makes New $6.55 Million Investment in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Short Interest Down 12.8% in February - MarketBeat
Brevan Howard Capital Management LP Buys Shares of 6,170 Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Jefferies downgrades Alnylam Pharmaceuticals (ALNY) - MSN
California Public Employees Retirement System Buys 18,060 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Bamco Inc. NY Acquires New Shares in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
(ALNY) and the Role of Price-Sensitive Allocations - Stock Traders Daily
A Look At Alnylam Pharmaceuticals (ALNY) Valuation After New Tenaya Cardiovascular Partnership - simplywall.st
JP Morgan Maintains Alnylam Pharmaceuticals (ALNY) Overweight Recommendation - MSN
ALNY Downgraded by Jefferies with Price Target Significantly Low - GuruFocus
Alnylam Pharmaceuticals (NASDAQ:ALNY) Earns Hold Rating from Jefferies Financial Group - MarketBeat
Jain Global LLC Purchases 61,316 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Here Are Monday’s Top Wall Street Analyst Research Calls: Alnylam Pharmaceuticals, Circle Internet, Fifth Third Bancorp, Intuit, ServiceNow, Qualcomm, Trade Desk, and More - 24/7 Wall St.
Patisiran Comprehensive Forecast on the Accelerating Market - openPR.com
6,888 Shares in Alnylam Pharmaceuticals, Inc. $ALNY Acquired by Capula Management Ltd - MarketBeat
Alnylam Pharmaceuticals, Inc. $ALNY is Casdin Capital LLC's 10th Largest Position - MarketBeat
Aquatic Capital Management LLC Acquires Shares of 84,059 Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Alnylam Pharmaceuticals, Inc. $ALNY Shares Purchased by Integral Health Asset Management LLC - MarketBeat
Dodge & Cox Has $1.06 Billion Stock Position in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
How TN-301 Progress And Alnylam Deal At Tenaya Therapeutics (TNYA) Has Changed Its Investment Story - simplywall.st
Quo Vadis mRNA Vaccine Technology? The State of the IP Lawsuits - JD Supra
Van ECK Associates Corp Sells 13,427 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Alnylam Pharmaceuticals, Inc. $ALNY Shares Bought by Quadrature Capital Ltd - MarketBeat
Entropy Technologies LP Boosts Position in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
siRNA Therapeutics Market Poised for Rapid Growth to US$ 12.38 - openPR.com
Arrowstreet Capital Limited Partnership Purchases 1,185,909 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Why Alnylam Pharmaceuticals Stock Was Soaring on Monday - AOL.com
Tenaya Therapeutics (TNYA) Is Up 47.7% After Positive TN-301 DMD Data And Alnylam Deal - Yahoo Finance
Alnylam Pharmaceuticals, Inc. $ALNY Shares Sold by Atika Capital Management LLC - MarketBeat
Alnylam Pharmaceuticals, Inc. $ALNY Stock Holdings Lifted by WINTON GROUP Ltd - MarketBeat
Legal & General Group Plc Has $404.83 Million Holdings in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
How Investors May Respond To Alnylam (ALNY) Expanding Cardiovascular RNAi Targets Through Tenaya Collaboration - simplywall.st
Capital Research Global Investors Boosts Holdings in Alnylam Pharmaceuticals - National Today
Alnylam to Webcast TTR Investor Webinar - Yahoo Finance
Capital Research Global Investors Boosts Holdings in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Alnylam Pharmaceuticals, Inc. $ALNY Shares Sold by Capital World Investors - MarketBeat
Alnylam Pharmaceuticals, Inc. $ALNY Stock Position Raised by Capital International Inc. CA - MarketBeat
Swiss National Bank Has $171.37 Million Stock Holdings in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Alnylam Pharmaceuticals, Inc. $ALNY Holdings Raised by Jefferies Financial Group Inc. - MarketBeat
First Trust Advisors LP Sells 41,434 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Barclays PLC Lowers Stake in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Alnylam Pharmaceuticals grants performance-based equity award to CEO - Investing.com Nigeria
12,658 Shares in Alnylam Pharmaceuticals, Inc. $ALNY Purchased by Fieldview Capital Management LLC - MarketBeat
Alnylam nabs key additional indication for Amvuttra - MSN
Assessing Alnylam Pharmaceuticals (ALNY) Valuation After New Cardiovascular Partnership With Tenaya Therapeutics - Sahm
Alnylam targets 25% revenue CAGR through 2030 amid AMVUTTRA launch momentum and pipeline expansion - MSN
Korea Investment CORP Grows Stake in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Rhenman & Partners Asset Management AB Has $14.54 Million Stock Holdings in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
3.01%
자본화:
|
볼륨(24시간):